BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 12133028)

  • 1. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
    Stys T; Lawson WE; Smaldone GC; Stys A
    Arch Intern Med; 2000 May; 160(10):1409-13. PubMed ID: 10826452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
    Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between aspirin and ACE inhibitors in patients with heart failure.
    Mahé I; Meune C; Diemer M; Caulin C; Bergmann JF
    Drug Saf; 2001; 24(3):167-82. PubMed ID: 11347721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and trials of cardiovascular outcomes.
    Sleight P
    Am J Cardiol; 2002 Jan; 89(2A):11A-16A; discussion 16A-17A. PubMed ID: 11835905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trials.
    Young JB
    Int J Cardiol; 1994 Feb; 43(2):151-63. PubMed ID: 8181869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
    Harjai KJ; Solis S; Prasad A; Loupe J
    Int J Cardiol; 2003 Apr; 88(2-3):207-14. PubMed ID: 12714200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
    Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
    J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the treatment of heart failure.
    Giles TD
    Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S21-7. PubMed ID: 7827370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.
    Parmley WW
    Am J Med; 1998 Jul; 105(1A):27S-31S. PubMed ID: 9707265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?
    Moskowitz R
    Curr Cardiol Rep; 2001 May; 3(3):247-53. PubMed ID: 11305980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
    Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
    Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Nguyen KN; Aursnes I; Kjekshus J
    Am J Cardiol; 1997 Jan; 79(2):115-9. PubMed ID: 9193008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.